Skip to main content

Table 1 Clinical characteristics of study subjects

From: DNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A binding

Characteristic Cases (n = 15) Controls (n = 17) P value
Age (years) 39.33 ± 5.94 36.12 ± 7.66 0.12
Male (n) 15 17 1
Serum uric acid (μmol/L) 535.80 ± 38.31 320.65 ± 66.80 1.42E−11
Creatinine (μmol/L) 68.80 ± 28.18 56.94 ± 12.00 0.21
Body mass index (kg/m2) 24.81 ± 3.64 22.16 ± 3.52 0.04
Cholesterol (mg/dL) 197.20 ± 99.09 134.24 ± 49.02 0.03
Triglycerides (mg/dL) 149.73 ± 33.21 120.29 ± 43.33 0.04
Cancer (n) 0 0 1
Smoker (n) 0 0 1
  1. Values are mean ± SD or numbers. P value for the difference between cases and controls